82 related articles for article (PubMed ID: 3432064)
41. Noninvasive methods for the early detection of doxorubicin-induced cardiomyopathy.
Lenzhofer R; Dudczak R; Gumhold G; Graninger W; Moser K; Spitzy KH
J Cancer Res Clin Oncol; 1983; 106(2):136-42. PubMed ID: 6630284
[TBL] [Abstract][Full Text] [Related]
42. Quantitative radionuclide angiocardiography.
Grégoire J; Parker JA; Holman BL
Cardiovasc Intervent Radiol; 1987; 10(6):384-99. PubMed ID: 3123064
[TBL] [Abstract][Full Text] [Related]
43. Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study.
Milei J; Marantz A; Alé J; Vazquez A; Buceta JE
Cancer Drug Deliv; 1987; 4(2):129-36. PubMed ID: 3427552
[TBL] [Abstract][Full Text] [Related]
44. [4'-epidoxorubicin: its cardiotoxicity. Possible cardiac protection with gallopamil, a drug with calcium-antagonist action].
Polverino W; Basso A; Bonelli A; Muto P; Cittadini A; Salvatore M
Minerva Cardioangiol; 1992; 40(1-2):23-30. PubMed ID: 1630667
[TBL] [Abstract][Full Text] [Related]
45. Doxorubicin hydrochloride (Adriamycin) cardiotoxicity evaluated by sequential radionuclide angiocardiography.
Piver MS; Marchetti DL; Parthasarathy KL; Bakshi S; Reese P
Cancer; 1985 Jul; 56(1):76-80. PubMed ID: 2988739
[TBL] [Abstract][Full Text] [Related]
46. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin.
Ewer MS; Ali MK; Mackay B; Wallace S; Valdivieso M; Legha SS; Benjamin RS; Haynie TP
J Clin Oncol; 1984 Feb; 2(2):112-7. PubMed ID: 6699662
[TBL] [Abstract][Full Text] [Related]
47. Antimyosin cardiac imaging: will it play a role in the detection of doxorubicin cardiotoxicity?
Jain D; Zaret BL
J Nucl Med; 1990 Dec; 31(12):1970-4. PubMed ID: 2266395
[No Abstract] [Full Text] [Related]
48. Hemodynamic effects of chronic 4'epi-adriamycin administration.
Milei J; Ale JJ; Garay G; Otero F; Comba AZ; Gugliotta HO; Storino RA
Cardiovasc Drugs Ther; 1990 Dec; 4(6):1519-23. PubMed ID: 2081145
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of technetium-99m red blood cell labeling efficiency in adults receiving chemotherapy and the clinical impact on pediatric oncology patients.
White MP; Mann A; Cross DM; Heller GV
J Nucl Med Technol; 1998 Dec; 26(4):265-8. PubMed ID: 9884940
[TBL] [Abstract][Full Text] [Related]
50. Assessment of the left ventricular function with the nuclear stethoscope.
Tarkowska A; Adam WE; Bitter F
Eur J Nucl Med; 1980 Aug; 5(4):333-8. PubMed ID: 7398670
[TBL] [Abstract][Full Text] [Related]
51. Abnormal myocardial image with 99mTc-pyrophosphate in a child on chemotherapy.
Sty JR; Garrett R
Clin Nucl Med; 1978 Feb; 3(2):65-6. PubMed ID: 657657
[No Abstract] [Full Text] [Related]
52. Adriamycin cardiotoxicity monitoring by radionuclide scan.
Robinson BA; Colls BM; Turner JG
Br J Cancer; 1983 Aug; 48(2):315-7. PubMed ID: 6882671
[No Abstract] [Full Text] [Related]
53. Technetium-99m red blood cell labeling in patients treated with doxorubicin.
Ballinger JR; Gerson B; Gulenchyn KY; Ruddy TD; Davies RA
Clin Nucl Med; 1988 Mar; 13(3):169-70. PubMed ID: 3383520
[TBL] [Abstract][Full Text] [Related]
54. The meaning of bites on the vectorcardiogram: study in adriamycin cardiomyopathy.
Vitolo E; Madoi S; Colli AM; Roveda M; La Rovere MT; Obbiassi M; Labianca R
J Electrocardiol; 1982; 15(3):265-70. PubMed ID: 7119636
[TBL] [Abstract][Full Text] [Related]
55. [Various side effects of adriamycin].
Pawlicki M; Stefański W; Migdal K; Dlugosz B
Nowotwory; 1977; 27(3):205-11. PubMed ID: 928074
[No Abstract] [Full Text] [Related]
56. [Cardiotoxic effect of adriamycin].
Shkhvatsabaia LV; Valvere VIu; Nekliudova VI
Kardiologiia; 1988 Apr; 28(4):110-4. PubMed ID: 3292809
[No Abstract] [Full Text] [Related]
57. What is the current status of quantification and nuclear medicine in cardiology?
Hör G
Eur J Nucl Med; 1996 Jul; 23(7):815-51. PubMed ID: 8662122
[No Abstract] [Full Text] [Related]
58. [Evaluation of adriamycin cardiotoxicity using equilibrium radionuclide ventriculography. I. Results at rest].
Knesewitsch P; Göldel NH; Fritsch S; Moser E
Nuklearmedizin; 1987 Oct; 26(5):206-11. PubMed ID: 3432064
[TBL] [Abstract][Full Text] [Related]
59. [Evaluation of adriamycin cardiotoxicity using equilibrium radionuclide ventriculography. II. Results during exercise].
Knesewitsch P; Göldel NH; Fritsch S; Moser E
Nuklearmedizin; 1987 Oct; 26(5):212-9. PubMed ID: 3432065
[TBL] [Abstract][Full Text] [Related]
60. [Quantitative resting radionuclide-ventriculography for multifactorial analysis of left ventricular function].
Knesewitsch P; Kleinhans E; Seiderer M; Klepzig M; Büll U
Nuklearmedizin; 1984 Aug; 23(4):163-9. PubMed ID: 6483626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
